Trial intelligence / Profile preview

Zanubrutinib plus R-CHOP in newly diagnosed MCD-subtype DLBCL

ChiCTR2200063452Phase 4Not yet recruiting

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Sep 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1